<i>CYP2C19</i> Polymorphism and Risk for Essential Tremor-Reference-Cited by-同舟云学术

CYP2C19 Polymorphism and Risk for Essential Tremor

Published:2006 Issue:2 Volume:56 Page:119-123
ISSN:0014-3022
Container-title:European Neurology
language:en
Short-container-title:Eur Neurol

Author:

Alonso-Navarro Hortensia,Martínez Carmen,García-Martín Elena,Benito-León Julián,García-Ferrer Isabel,Vázquez-Torres Pilar,Puertas Inmaculada,López-Alburquerque Tomás,Agúndez José A.G.,Jiménez-Jiménez Félix Javier

Publisher

S. Karger AG

Subject

Clinical Neurology,Neurology

Reference32 articles.

1. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects

2. Clinical features of essential tremor seen in neurology practice: a study of 357 patients

3. Jimenez-Jimenez FJ, Tallon-Barranco A, Vazquez A: Temblor esencial; in Jimenez-Jimenez FJ, Luquin MR, Molina JA (eds): Tratado de los trastornos del movimiento. Madrid, IM&C, 1998, pp 567-591.

4. Essential tremor

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia;Neuropathology and Applied Neurobiology;2023-01-17

2. Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor;Molecular Neurobiology;2022-03-24

3. Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain;Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary;2022

4. Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs;Frontiers in Pharmacology;2021-09-21

5. Genomic Markers for Essential Tremor;Pharmaceuticals;2021-05-27